NextCure Inc at Bank of America Biotech SMID Cap Conference Transcript
Ladies and gentleman, the program is about to begin. Reminder that you can submit questions at any time via the ask questions tab on the webcast page. At this time, it is my pleasure to turn the program over to your host, Alec Stranahan.
Okay. Hello, everyone. Welcome to the end of day 2 of the 2022 Bank of America Healthcare Conference, and thanks for joining the session with next cure. My name is Alex Stranahan. I'm Vice President and Senior Biotic analysts covering NextCure here at BofA. And I'm pleased to be joined by Michael Richman. President and Chief Executive Officer of NextCure. Michael, thanks for joining.
Thank you, Alec. Great to be here, and thanks for including us in this year's conference.
Great. Great. So I believe I believe Michael is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |